Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , IPO , cancer , drugs , Taiwan

Next In Business News

MSPO certification helps Malaysia meet sustainability requirements in FTAs, says MPOB
Teamstar signs underwriting agreement with TA Securities for ACE Market IPO
Melati Ehsan redesignates COO to CEO
TM Nxera partners with TNB to secure 280MW for data centre campus
Favelle Favco acquires France-based Seram Industries SAS
Ringgit ends firmer as concerns over Fed independence weigh on US dollar
HE Group wins power distribution system contract
Awanbiru appoints Azizah Ali as its group CEO
MN Holdings proposes transfer to the Main Market of Bursa Securities
Vantris Energy divests stake in L&T-Sapura Shipping for 124mil

Others Also Read